These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30369997)

  • 21. Validation of the Chinese version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Wang BR; Ou Z; Gu XH; Wei CS; Xu J; Shi JQ
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):e173-e179. PubMed ID: 28170114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hindi Version of Addenbrooke's Cognitive Examination III: Distinguishing Cognitive Impairment Among Older Indians at the Lower Cut-Offs.
    Bajpai S; Upadhyay A; Sati H; Pandey RM; Chaterjee P; Dey AB
    Clin Interv Aging; 2020; 15():329-339. PubMed ID: 32184582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Spanish version of Addenbrooke's Cognitive Examination III for diagnosing dementia.
    Matias-Guiu JA; Fernández de Bobadilla R; Escudero G; Pérez-Pérez J; Cortés A; Morenas-Rodríguez E; Valles-Salgado M; Moreno-Ramos T; Kulisevsky J; Matías-Guiu J
    Neurologia; 2015; 30(9):545-51. PubMed ID: 25002342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment.
    Beishon LC; Batterham AP; Quinn TJ; Nelson CP; Panerai RB; Robinson T; Haunton VJ
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013282. PubMed ID: 31846066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Egyptian-Arabic Version of the Addenbrooke's Cognitive Examination III (ACE-III) in Diagnosing Dementia.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Abdel Aziz K
    Dement Geriatr Cogn Disord; 2020; 49(2):179-184. PubMed ID: 32417842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of the Thai version of the Mini-Addenbrooke's Cognitive Examination as a mild cognitive impairment and dementia screening test.
    Charernboon T
    Psychogeriatrics; 2019 Jul; 19(4):340-344. PubMed ID: 30699469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
    Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
    Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation and Validation of Addenbrooke's Cognitive Examination-III in Bengali for Screening MCI and Dementia.
    Bhattacharyya B; Mukherjee R; Mukherjee A; Das G; Dogra AK; Das S; Biswas A
    Arch Clin Neuropsychol; 2022 Oct; 37(7):1619-1627. PubMed ID: 35780304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the Addenbrooke's Cognitive Examination-III in Mild Cognitive Impairment in Arabic Speakers in Egypt.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Saber HG; Aly El-Gabry D; Abdel Aziz K
    Dement Geriatr Cogn Disord; 2020; 49(4):418-422. PubMed ID: 33080612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals.
    North C; Heatley MH; Utoomprurkporn N; Bamiou DE; Costafreda SG; Stott J
    Eur J Neurol; 2021 Jun; 28(6):1820-1828. PubMed ID: 33486875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addenbrooke's Cognitive Examination and Individual Domain Cut-Off Scores for Discriminating between Different Cognitive Subtypes of Parkinson's Disease.
    Berankova D; Janousova E; Mrackova M; Eliasova I; Kostalova M; Skutilova S; Rektorova I
    Parkinsons Dis; 2015; 2015():579417. PubMed ID: 26351616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addenbrooke's cognitive examination-revised: normative and accuracy data for seniors with heterogeneous educational level in Brazil.
    César KG; Yassuda MS; Porto FHG; Brucki SMD; Nitrini R
    Int Psychogeriatr; 2017 Aug; 29(8):1345-1353. PubMed ID: 28511735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke's Cognitive Examination-Revised, and Montreal Cognitive Assessment.
    Ridley N; Batchelor J; Draper B; Demirkol A; Lintzeris N; Withall A
    J Clin Exp Neuropsychol; 2018 Mar; 40(2):107-122. PubMed ID: 28436744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
    Li X; Yang L; Yin J; Yu N; Ye F
    J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population.
    Hancock P; Larner AJ
    Int Psychogeriatr; 2009 Jun; 21(3):526-30. PubMed ID: 19327203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.